Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TESO
1701
DELISTED
Tesco Corp
TESO
| $2.86M | 0.01% |
262,787
-405,468
| -61% | -$4.87M |
|
|
XOMA
1702
PUT
DELISTED
Xoma
XOMA
| $2.86M | 0.01% |
+36,880
| New | +$2.66M |
|
1703
PUT
Franco-Nevada
FNV
$52.4B
| $2.86M | 0.01% |
+60,000
| New | +$3.04M |
|
1704
Coeur Mining
CDE
$22.2B
| $2.85M | 0.01% |
499,134
+149,673
| +43% | +$820K |
|
1705
PUT
Ralph Lauren
RL
$21.6B
| $2.85M | 0.01% |
21,500
-1,200
| -5% | -$162K |
|
|
GWPH
1706
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.83M | 0.01% |
23,080
-2,940
| -11% | -$334K |
|
1707
SolarEdge
SEDG
$1.84B
| $2.83M | 0.01% |
77,960
-86,502
| -53% | -$2.79M |
|
1708
Amphenol
APH
$196B
| $2.81M | 0.01% |
193,880
-126,980
| -40% | -$1.82M |
|
|
AVG
1709
DELISTED
AVG Technologies N.V.
AVG
| $2.81M | 0.01% |
103,114
-34,975
| -25% | -$852K |
|
|
INVN
1710
DELISTED
Invensense Inc
INVN
| $2.79M | 0.01% |
+185,019
| New | +$2.79M |
|
|
PETX
1711
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.79M | 0.01% |
184,345
+116,943
| +174% | +$1.69M |
|
|
SNOW
1712
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $2.75M | 0.01% |
236,861
+162,575
| +219% | +$1.79M |
|
1713
Carpenter Technology
CRS
$24.1B
| $2.74M | 0.01% |
70,780
-99,673
| -58% | -$4.16M |
|
1714
Rayonier
RYN
$6.32B
| $2.74M | 0.01% |
+118,076
| New | +$2.77M |
|
1715
ArcBest
ARCB
$3.03B
| $2.73M | 0.01% |
86,018
+20,203
| +31% | +$722K |
|
|
IM
1716
DELISTED
Ingram Micro
IM
| $2.7M | 0.01% |
107,874
-112,320
| -51% | -$2.94M |
|
|
TSE
1717
DELISTED
Trinseo
TSE
| $2.7M | 0.01% |
100,551
+88,964
| +768% | +$2.28M |
|
1718
Tesla
TSLA
$1.38T
| $2.69M | 0.01% |
150,615
-74,385
| -33% | -$1.18M |
|
|
UBNK
1719
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.68M | 0.01% |
199,509
+183,205
| +1,124% | +$2.37M |
|
1720
Kadant
KAI
$3.58B
| $2.68M | 0.01% |
56,732
+30,602
| +117% | +$1.53M |
|
|
XCO
1721
DELISTED
Exco Resources
XCO
| $2.68M | 0.01% |
+151,197
| New | +$3.95M |
|
1722
Applied Industrial Technologies
AIT
$12.3B
| $2.67M | 0.01% |
67,465
+47,296
| +234% | +$2.01M |
|
1723
Ingles Markets
IMKTA
$1.61B
| $2.67M | 0.01% |
+56,001
| New | +$2.7M |
|
1724
Ardelyx
ARDX
$976M
| $2.67M | 0.01% |
+167,408
| New | +$2.11M |
|
1725
Enviri
NVRI
$609M
| $2.67M | 0.01% |
161,835
+121,311
| +299% | +$2M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.